GAMMA Investing
AKBA icon

GAMMA Investing’s Akebia Therapeutics AKBA Stock Holding History

GAMMA Investing’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.08K Buy
+6,614
New +$7.11K ﹤0.01% 3571
2026
Q2 		– Sell
-382
Closed -$531 – 4141
2026
Q1 		$531 Buy
+382
New +$525 ﹤0.01% 3936

Other funds holding AKBA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

GAMMA Investing's AKBA Position: Q3 2026 in Review

GAMMA Investing opened a new position in Akebia Therapeutics (AKBA) in Q3 2026: 6,614 shares worth $6.08K. The stake represents ﹤0.01% of the portfolio and ranks #3571 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in AKBA as recently as Q1 2026.

GAMMA Investing first reported a position in AKBA in Q1 2026 and has held it in 2 quarters since. 57 funds tracked by Wall St. Rank hold AKBA as of Q3 2026.

  • GAMMA Investing held 6,614 shares of Akebia Therapeutics worth $6.08K as of Q3 2026.
  • Akebia Therapeutics was a new GAMMA Investing position in Q3 2026.
  • Akebia Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3571 holding.
  • GAMMA Investing first reported a position in Akebia Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 57 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.